Rob Dallimore is a seasoned quality assurance professional currently serving as Vice President of Quality at Wugen since 2024. They have held multiple leadership roles, including Vice President of Quality at MacroGenics, Inc. from 2013 to 2022 and Senior Vice President of Quality and Compliance at Innovative Cellular Therapeutics from 2022 to 2024. Rob began their career as a Research Chemist at Sigma Aldrich and Palmer Research from 1990 to 1999 and has extensive experience in quality operations, having been the Head of Quality Operations at Intercell AG from 2008 to 2011. They hold a degree in Chemistry from the University of Wales, Bangor, which they completed in 1990.
This person is not in the org chart
This person is not in any teams
This person is not in any offices